For us, the most meaningful part is why we won the award: helping scientists spend less time managing supply orders while giving procurement and finance the visibility and control they need.
The Frost & Sullivan announcement highlights ZAGENO’s evolution beyond online purchasing into procurement orchestration. Here’s why that matters for pharmaceutical and biotech R&D.
The announcement highlights how ZAGENO brings sourcing, ordering, approvals, tracking, and payment into a coordinated process. It emphasizes the platform's ability to connect scientific purchasing directly with enterprise resource planning (ERP) and procure-to-pay (P2P) systems like SAP, Coupa, and Oracle NetSuite.
As Ana Dominguez, Best Practices Research Analyst at Frost & Sullivan, explained:
“ZAGENO continues to redefine digital procurement by extending life sciences e-commerce beyond an online marketplace into a procurement orchestration platform. Its ability to unify supplier networks, enterprise systems, governance, and intelligent automation within a single workflow helps reduce procurement friction while enabling researchers and procurement teams to operate more efficiently.”
For our team, this validates the direction of our work in scientific procurement orchestration: making the steps behind a lab purchase work together, so researchers and the teams supporting them spend less time coordinating those steps themselves.
Frost & Sullivan’s analysis focuses on tangible operational outcomes across the three primary stakeholders in lab purchasing:
ZAGENO has been expanding its platform architecture and supplier ecosystem since 2015. Frost & Sullivan previously recognized our work in 2022 and 2024, followed by its 2025 Global Company of the Year recognition in life sciences e-commerce.
Our customers and suppliers help shape that work through the needs and feedback they share with us. Our team brings those improvements to life. We’re grateful to everyone who has helped us reach this milestone.